CYP51A polymorphisms of Aspergillus fumigatus in lung transplant recipients: Prevalence, correlation with phenotype, and impact on outcomes.
暂无分享,去创建一个
S. Keshavjee | T. Mazzulli | S. Husain | J. Kus | L. Singer | F. Cheema | L. McTaggart | A. Guenette | B. Henry | Armelle Pérez-Cortés
[1] G. Garcia-Effron,et al. High prevalence of triazole‐resistant Aspergillus fumigatus sensu stricto in an Argentinean cohort of patients with cystic fibrosis , 2020, Mycoses.
[2] E. Kuijper,et al. Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013–2018 , 2020, Emerging infectious diseases.
[3] J. Guarro,et al. Update and recent advances on azole resistance mechanisms in Aspergillus. , 2020, International journal of antimicrobial agents.
[4] L. Millon,et al. Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients , 2019, Emerging infectious diseases.
[5] W. Melchers,et al. Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients - A Dutch, multicentre study. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[6] C. Deluca,et al. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods , 2018, Antimicrobial Agents and Chemotherapy.
[7] W. Melchers,et al. Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] Brendan R. Jackson,et al. Multidrug-Resistant Aspergillus fumigatus Carrying Mutations Linked to Environmental Fungicide Exposure — Three States, 2010–2017 , 2018, MMWR. Morbidity and mortality weekly report.
[9] O. Lortholary,et al. Failure of voriconazole therapy due to acquired azole resistance in Aspergillus fumigatus in a kidney transplant recipient with chronic necrotizing aspergillosis , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] Yeon-Joon Park,et al. TR34/L98H Mutation in CYP51A Gene in Aspergillus fumigatus Clinical Isolates During Posaconazole Prophylaxis: First Case in Korea , 2018, Mycopathologia.
[11] C. Beigelman-Aubry,et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[12] F. Bouwman,et al. Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study , 2018, The Journal of antimicrobial chemotherapy.
[13] A. Chowdhary,et al. Triazole resistance surveillance in Aspergillus fumigatus. , 2018, Medical mycology.
[14] E. Berkow,et al. Detection of TR34/L98H CYP51A Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017 , 2018, Antimicrobial Agents and Chemotherapy.
[15] D. Sanglard,et al. Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance. , 2016, Medical mycology.
[16] E. Manavathu,et al. Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States , 2015, Antimicrobial Agents and Chemotherapy.
[17] A. Chowdhary,et al. Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing , 2015, mBio.
[18] P. Hauser,et al. Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus , 2015, Emerging infectious diseases.
[19] D. Buchheidt,et al. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. , 2015, The Journal of antimicrobial chemotherapy.
[20] P. Le Pape,et al. First Description of Azole-Resistant Aspergillus fumigatus Due to TR46/Y121F/T289A Mutation in France , 2015, Antimicrobial Agents and Chemotherapy.
[21] W. Kremers,et al. Epidemiology of invasive fungal infections in lung transplant recipients on long‐term azole antifungal prophylaxis , 2015, Clinical transplantation.
[22] S. Keshavjee,et al. Rate of cyp51A mutation in Aspergillus fumigatus among lung transplant recipients with targeted prophylaxis. , 2015, The Journal of antimicrobial chemotherapy.
[23] J. Meis,et al. Passive Surveillance for Azole-Resistant Aspergillus fumigatus, United States, 2011–2013 , 2014, Emerging infectious diseases.
[24] O. Hilberg,et al. First Detection of TR46/Y121F/T289A and TR34/L98H Alterations in Aspergillus fumigatus Isolates from Azole-Naive Patients in Denmark despite Negative Findings in the Environment , 2014, Antimicrobial Agents and Chemotherapy.
[25] D. Denning,et al. High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates. , 2013, The Journal of antimicrobial chemotherapy.
[26] S. Brisse,et al. Azole Preexposure Affects the Aspergillus fumigatus Population in Patients , 2012, Antimicrobial Agents and Chemotherapy.
[27] E. Kuijper,et al. Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature , 2011, Antimicrobial Agents and Chemotherapy.
[28] W. Melchers,et al. Failure of Posaconazole Therapy in a Renal Transplant Patient with Invasive Aspergillosis Due to Aspergillus fumigatus with Attenuated Susceptibility to Posaconazole , 2011, Antimicrobial Agents and Chemotherapy.
[29] M. Hannan,et al. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients , 2011, The Journal of Heart and Lung Transplantation.
[30] P. Escribano,et al. Aspergillus fumigatus Strains with Mutations in the cyp51A Gene Do Not Always Show Phenotypic Resistance to Itraconazole, Voriconazole, or Posaconazole , 2011, Antimicrobial Agents and Chemotherapy.
[31] C. Cordonnier,et al. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. , 2011, The Journal of antimicrobial chemotherapy.
[32] E. Anaissie,et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] W. Melchers,et al. Azole Resistance Profile of Amino Acid Changes in Aspergillus fumigatus CYP51A Based on Protein Homology Modeling , 2010, Antimicrobial Agents and Chemotherapy.
[34] W. Melchers,et al. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? , 2009, The Lancet. Infectious diseases.
[35] D. Denning,et al. Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure , 2009, Emerging infectious diseases.
[36] J. Perfect,et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] Yee-Chun Chen,et al. Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan , 2018, Environmental microbiology.